These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9734679)

  • 1. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold.
    Zeidler HK; Kvien TK; Hannonen P; Wollheim FA; Førre O; Geidel H; Hafström I; Kaltwasser JP; Leirisalo-Repo M; Manger B; Laasonen L; Markert ER; Prestele H; Kurki P
    Br J Rheumatol; 1998 Aug; 37(8):874-82. PubMed ID: 9734679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension.
    Kvien TK; Zeidler HK; Hannonen P; Wollheim FA; Førre O; Hafström I; Kaltwasser JP; Leirisalo-Repo M; Manger B; Laasonen L; Prestele H; Kurki P
    Ann Rheum Dis; 2002 Jun; 61(6):511-6. PubMed ID: 12006323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A.
    Pasero G; Priolo F; Marubini E; Fantini F; Ferraccioli G; Magaro M; Marcolongo R; Oriente P; Pipitone V; Portioli I; Tirri G; Trotta F; Della Casa-Alberighi O
    Arthritis Rheum; 1996 Jun; 39(6):1006-15. PubMed ID: 8651963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis.
    Menninger H; Herborn G; Sander O; Blechschmidt J; Rau R
    Br J Rheumatol; 1998 Oct; 37(10):1060-8. PubMed ID: 9825744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients.
    Rau R; Herborn G; Menninger H; Sangha O
    Rheumatology (Oxford); 2002 Feb; 41(2):196-204. PubMed ID: 11886970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study.
    Peltomaa R; Paimela L; Helve T; Leirisalo-Repo M
    Scand J Rheumatol; 1995; 24(6):330-5. PubMed ID: 8610215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: an interim report on 102 patients after 12 months.
    Rau R; Herborn G; Karger T; Menninger H; Elhardt D; Schmitt J
    Semin Arthritis Rheum; 1991 Oct; 21(2 Suppl 1):13-20. PubMed ID: 1749945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
    Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
    Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients.
    Rau R; Herborn G; Menninger H; Blechschmidt J
    Br J Rheumatol; 1997 Mar; 36(3):345-52. PubMed ID: 9133967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis.
    Bendix G; Bjelle A
    Ann Rheum Dis; 1996 Mar; 55(3):169-76. PubMed ID: 8712879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern treatment strategies in rheumatoid arthritis.
    Hetland ML
    Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.
    Zhou YZ; Zhao LD; Chen H; Zhang Y; Wang DF; Huang LF; Lv QW; Liu B; Li Z; Wei W; Li H; Liao X; Liu H; Liu X; Jin H; Wang J; Fei YY; Wu QJ; Zhang W; Shi Q; Zheng WJ; Zhang FC; Tang FL; Lipsky PE; Zhang X
    Arthritis Res Ther; 2018 Apr; 20(1):70. PubMed ID: 29636089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
    Smolen JS; Van Der Heijde DM; St Clair EW; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Schiff M; Baker D; Han C; Han J; Bala M;
    Arthritis Rheum; 2006 Mar; 54(3):702-10. PubMed ID: 16508926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis.
    Marchesoni A; Battafarano N; Arreghini M; Pellerito R; Cagnoli M; Prudente P; Cerase A; Priolo F; Tosi S
    Arthritis Rheum; 2002 Feb; 47(1):59-66. PubMed ID: 11932879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate.
    Rau R; Herborn G; Menninger H; Sangha O
    Br J Rheumatol; 1998 Nov; 37(11):1220-6. PubMed ID: 9851273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
    Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
    Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
    Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
    J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does parenteral gold inhibit roentgen progression of chronic polyarthritis?].
    Rau R
    Z Rheumatol; 1996; 55(5):307-18. PubMed ID: 9036717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development and evaluation of a modified version of the Larsen method for evaluating roentgenologic changes in chronic polyarthritis].
    Rau R; Herborn G
    Z Rheumatol; 1997; 56(3):127-35. PubMed ID: 9340953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.